Lam WS, Creaney J, Chen FK, Chin WL, et al. A phase II trial of single oral FGF inhibitor, AZD4547, as second or third line therapy in malignant pleural mesothelioma. Lung Cancer 2020;140:87-92.
PMID: 31901768